 |
 Previous Article | Next Article 
The Journal of Neuroscience, July 1, 2001, 21(13):4875-4882
The  2A-Adrenergic Receptor Plays a Protective Role
in Mouse Behavioral Models of Depression and Anxiety
Nicole L.
Schramm,
Michael P.
McDonald, and
Lee E.
Limbird
Department of Pharmacology and Center for Molecular Neuroscience,
Vanderbilt University School of Medicine, Nashville, Tennessee
37232-6600
The noradrenergic system is involved in the regulation of many
physiological and psychological processes, including the modulation of
mood. The  2-adrenergic receptors (2-ARs)
modulate norepinephrine release, as well as the release of
serotonin and other neurotransmitters, and are therefore potential
targets for antidepressant and anxiolytic drug development. The current
studies were undertaken to examine the role of the 2A
subtype of 2-AR in mouse behavioral models of depression
and anxiety. We have observed that the genetic knock-out of the
2A-AR makes mice less active in a modified version of Porsolt's forced swim test and insensitive to the antidepressant effects of the tricyclic drug imipramine in this paradigm. Furthermore, 2A-AR knock-out mice appear more anxious than
wild-type C57 Bl/6 mice in the rearing and light-dark
models of anxiety after injection stress. These findings suggest that
the 2A-AR may play a protective role in some forms of
depression and anxiety and that the antidepressant effects of
imipramine may be mediated by the 2A-AR.
Key words:
antidepressant; adrenergic receptor; anxiety; forced
swim; imipramine; light-dark test
Copyright © 2001 Society for Neuroscience 0270-6474/01/21134875-08$05.00/0
This article has been cited by other articles:
|
|
|
|
 
J.-K. Chen, J. Chen, J. D. Imig, S. Wei, D. L. Hachey, J. S. Guthi, J. R. Falck, J. H. Capdevila, and R. C. Harris
Identification of Novel Endogenous Cytochrome P450 Arachidonate Metabolites with High Affinity for Cannabinoid Receptors
J. Biol. Chem.,
September 5, 2008;
283(36):
24514 - 24524.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Allan, X. Liang, Y. Luo, C. Pak, X. Li, K. E. Szulwach, D. Chen, P. Jin, and X. Zhao
The loss of methyl-CpG binding protein 1 leads to autism-like behavioral deficits
Hum. Mol. Genet.,
July 1, 2008;
17(13):
2047 - 2057.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Olsen, Y. Huang, S. Goodwin, D. C. Ciobanu, L. Lu, T. R. Sutter, and D. G. Winder
Microarray analysis reveals distinctive signaling between the bed nucleus of the stria terminalis, nucleus accumbens, and dorsal striatum
Physiol Genomics,
February 19, 2008;
32(3):
283 - 298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R.H. Belmaker and G. Agam
Major Depressive Disorder
N. Engl. J. Med.,
January 3, 2008;
358(1):
55 - 68.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. G. Wilson, S. Akhter, C. A. Mayer, P. Kc, K. V. Balan, P. Ernsberger, and M. A. Haxhiu
Allergic lung inflammation affects central noradrenergic control of cholinergic outflow to the airways in ferrets
J Appl Physiol,
December 1, 2007;
103(6):
2095 - 2104.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Fukui, R. M. Rodriguiz, J. Zhou, S. X. Jiang, L. E. Phillips, M. G. Caron, and W. C. Wetsel
Vmat2 Heterozygous Mutant Mice Display a Depressive-Like Phenotype
J. Neurosci.,
September 26, 2007;
27(39):
10520 - 10529.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. G. Cameron, G. C. Huang, T. Nichols, R. A. Koeppe, S. Minoshima, D. Rose, and K. A. Frey
Reduced {gamma}-Aminobutyric AcidA-Benzodiazepine Binding Sites in Insular Cortex of Individuals With Panic Disorder
Arch Gen Psychiatry,
July 1, 2007;
64(7):
793 - 800.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. D. Deupree, A. L. Reed, and D. B. Bylund
Differential Effects of the Tricyclic Antidepressant Desipramine on the Density of Adrenergic Receptors in Juvenile and Adult Rats
J. Pharmacol. Exp. Ther.,
May 1, 2007;
321(2):
770 - 776.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Liu, E. Y. Yuen, P. B. Allen, J. Feng, P. Greengard, and Z. Yan
Adrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilin
PNAS,
November 28, 2006;
103(48):
18338 - 18343.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. R. Albert and S. Lemonde
5-HT1A Receptors, Gene Repression, and Depression: Guilt by Association
Neuroscientist,
December 1, 2004;
10(6):
575 - 593.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Q. Wei, X.-Y. Lu, L. Liu, G. Schafer, K.-R. Shieh, S. Burke, T. E. Robinson, S. J. Watson, A. F. Seasholtz, and H. Akil
Glucocorticoid receptor overexpression in forebrain: A mouse model of increased emotional lability
PNAS,
August 10, 2004;
101(32):
11851 - 11856.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. S. Charney and H. K. Manji
Life Stress, Genes, and Depression: Multiple Pathways Lead to Increased Risk and New Opportunities for Intervention
Sci. Signal.,
March 23, 2004;
2004(225):
re5 - re5.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Bilkei-Gorzo, I. Racz, K. Michel, and A. Zimmer
Diminished Anxiety- and Depression-Related Behaviors in Mice with Selective Deletion of the Tac1 Gene
J. Neurosci.,
November 15, 2002;
22(22):
10046 - 10052.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Franowicz, L. E. Kessler, C. M. D. Borja, B. K. Kobilka, L. E. Limbird, and A. F. T. Arnsten
Mutation of the alpha 2A-Adrenoceptor Impairs Working Memory Performance and Annuls Cognitive Enhancement by Guanfacine
J. Neurosci.,
October 1, 2002;
22(19):
8771 - 8777.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Tan, M. H. Wilson, L. B. MacMillan, B. K. Kobilka, and L. E. Limbird
Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists
PNAS,
September 17, 2002;
99(19):
12471 - 12476.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Philipp, M. Brede, and L. Hein
Physiological significance of alpha 2-adrenergic receptor subtype diversity: one receptor is not enough
Am J Physiol Regulatory Integrative Comp Physiol,
August 1, 2002;
283(2):
R287 - R295.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
